Dr. Aamir Badruddin, M.D.
Neurology (Neurocritical Care Physician)
901 Macarthur Blvd
Munster, IN 46321
Who else practices at this address →
Lake County includes primary care (18% of residents) shortage areas. About shortage areas
- Medicare participating
At a glance
- Medical school
- Rush Medical College of Rush University (2004)
- Years since graduation
- 22
- In the NPI registry since
- 2008
- Medicare patients seen, 2024
- 419
Licensed in Illinois since 2008, according to the Illinois Department of Financial and Professional Regulation. We show license dates only for the states that publish them in bulk; see which states do. For other states, check the state medical board.
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 2004Medical school: Rush Medical College of Rush University
- 2008Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Neurocritical Care Physician primary
IN license 01081926A -
Neurological Surgery Physician
IL license 036.120881 (first issued 2008; active) -
Neurology Physician
IL license 036120881 (first issued 2008; active) -
Neuroradiology Physician
IL license 036.120881 (first issued 2008; active) -
Vascular Neurology Physician
IL license 036.120881 (first issued 2008; active) · IN license 01081926A
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Community Hospital Munster, IN
- St Mary Medical Center Inc Hobart, IN
- St Catherine Hospital Inc East Chicago, IN
- Northwest Health - Porter Valparaiso, IN
Medical groups
- Community Care Network Inc (379 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 419
- Services billed
- 1,213
- Patients’ average age
- 76
| Service | Times | Patients |
|---|---|---|
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | 299 | 158 |
| Critical care, first 30-74 minutes | 237 | 138 |
| Established patient office or other outpatient visit, 30-39 minutes | 112 | 95 |
| Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | 87 | 87 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 54 | 49 |
| Insertion of tube into internal neck artery for diagnosis or treatment with review by radiologist | 46 | 44 |
| Insertion of tube into brain artery for diagnosis or treatment with review by radiologist | 42 | 41 |
| Insertion of tube into chest artery for diagnosis or treatment with review by radiologist | 39 | 38 |
| Established patient office or other outpatient visit, 10-19 minutes | 29 | 27 |
| New patient office or other outpatient visit, 45-59 minutes | 28 | 28 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Clopidogrel (clopidogrel bisulfate) Other prescribers in Munster, IN | 18 |
| Atorvastatin Calcium Other prescribers in Munster, IN | 12 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 6 companies reported 14 payments worth $1,264 in total to this clinician.
| Imperative Care, Inc | $759 |
|---|---|
| Stryker Corporation | $189 |
| Medtronic, Inc. | $150 |
| Penumbra, Inc. | $129 |
| DePuy Synthes Sales Inc. | $23.03 |
| Cordis US Corp. | $13.98 |
| Travel and Lodging | $759 |
|---|---|
| Food and Beverage | $506 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Imperative Care, Inc Apr 9, 2025 | Travel and Lodging ZOOM 88-T LARGE DISTAL PLATFORM · VASCULAR · travel to SAN JOSE, CA · in-kind | $442 |
| Imperative Care, Inc Apr 25, 2025 | Travel and Lodging ZOOM 88-T LARGE DISTAL PLATFORM · VASCULAR · travel to CAMPBELL, CA · in-kind | $135 |
| Imperative Care, Inc Apr 29, 2025 | Travel and Lodging ZOOM 88-T LARGE DISTAL PLATFORM · VASCULAR · travel to CAMPBELL, CA · in-kind | $135 |
| Imperative Care, Inc Apr 9, 2025 | Travel and Lodging ZOOM 88-T LARGE DISTAL PLATFORM · VASCULAR · travel to SAN JOSE, CA · in-kind | $31.25 |
| Imperative Care, Inc Apr 25, 2025 | Travel and Lodging ZOOM 88-T LARGE DISTAL PLATFORM · VASCULAR · travel to CAMPBELL, CA · in-kind | $15.75 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 2 industry-funded studies in 2025, from 2 companies. The companies reported $28,926 in research payments for these studies, mostly to the institutions running them.
- Tenecteplase in Acute Ischemic Stroke A Pharmacokinetic Study
Genentech, Inc. - A Study of Milvexian in Participants After an Acute Ischemic Stroke or High-Risk Transient Ischemic Attack- LIBREXIA-STROKE (LIBREXIA-STROK)
Janssen Research & Development, LLC
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.